U.S. Commercial Services Stock News

Immunome has submitted a New Drug Application to the FDA for varegacestat, an oral once-daily gamma secretase inhibitor for adults with desmoid tumors, backed by a global Phase 3 RINGSIDE trial that met its primary and key secondary endpoints. A key insight is that RINGSIDE is the largest randomized study conducted in this rare tumor type, with data selected for oral presentation at the 2026 ASCO Annual Meeting, highlighting the clinical community’s interest in varegacestat’s profile. We’ll...

Trevi Therapeutics recently announced plans to present detailed Phase 2b CORAL trial results and additional nalbuphine ER data for IPF-related chronic cough at the ATS 2026 International Conference in Orlando on May 18, 2026. Alongside upcoming Q1 2026 results and a proposal to double authorized common shares, these scientific disclosures highlight how clinical and corporate actions may shape Trevi’s future options for funding and advancing Haduvio. We’ll now examine how the upcoming Phase...

Stock performance snapshot and recent context PTC Therapeutics (PTCT) has drawn investor attention after recent trading, with the stock last closing at $65.49. The company operates in the rare disease biopharma space, with products spanning Duchenne muscular dystrophy and spinal muscular atrophy. See our latest analysis for PTC Therapeutics. Recent trading has been choppy, with a 1-day share price return of 0.52% compared with a 90-day share price return of 12.48% and a 1-year total...

Context for First Horizon stock First Horizon (FHN) has drawn fresh attention after a recent move in its share price, with the stock closing at US$24.63 and showing mixed returns over the past month and past 3 months. See our latest analysis for First Horizon. For context, this recent pullback follows a 6.3% 1 month share price return, while the stock’s 1 year and 3 year total shareholder returns of 34.5% and over 150% point to momentum that has built over time rather than faded. If First...

In the first quarter ended March 31, 2026, Essential Properties Realty Trust, Inc. reported revenue of US$158.8 million and net income of US$59.79 million, both higher than a year earlier, while basic and diluted EPS from continuing operations edged slightly lower to US$0.28. The combination of rising revenue and net income alongside nearly full occupancy and disciplined, low-leverage growth has reinforced Essential Properties Realty Trust’s reputation for resilient cash flows in the triple...

What Eagle Materials' Recent Moves Mean For Shareholders Eagle Materials (EXP) has drawn fresh attention after a recent pullback left the stock with a negative 1 day and past week return, despite a gain over the past month. See our latest analysis for Eagle Materials. The recent 1 day and 7 day share price declines sit against an 8.95% 1 month share price return. The 1 year total shareholder return of a 12.40% decline contrasts with a 5 year total shareholder return of 41.24%, suggesting...

Eve Holding, Inc. has reported first quarter 2026 results, recording a net loss of US$68.81 million, higher than the US$48.78 million loss in the same period last year. This widening loss underlines the financial strain of Eve’s ongoing eVTOL development phase and raises fresh questions about how its cash resources will support the path to commercialization. We’ll now explore how this larger quarterly net loss may influence Eve Holding’s investment narrative built around future urban air...

Schrödinger, Inc. recently reported its Q1 2026 results after the market close on May 5, 2026, and held its earnings call the same day, following earlier announcements that management would also appear at major May healthcare investor conferences hosted by BofA Securities and RBC. These events highlight Schrödinger’s efforts to spotlight its AI-enabled computational platform and growing hosted software model to a wider base of investors and potential users. We’ll now examine how the upcoming...

Innoviva’s Shelf Registration and What It Could Mean for Shareholders Innoviva (INVA) has filed a shelf registration to potentially offer up to US$207.99 million of common stock, covering 9,000,000 shares in an ESOP related transaction that could influence future valuation. See our latest analysis for Innoviva. Against the backdrop of this shelf registration and a fresh equity incentive plan, Innoviva’s recent share price return has been mixed in the very short term, but supported by stronger...

In late April 2026, Schneider National, Inc. reported first‑quarter results showing mostly flat revenue at US$1,398.5 million and lower net income of US$20.4 million year on year, while also completing a US$5.21 million share repurchase, affirming a US$0.10 quarterly dividend, and updating its bylaws to strengthen the role of the lead independent director in board leadership and succession. An interesting angle is that Schneider paired an earnings-per-share beat relative to analyst...

Recent commentary around Edgewell Personal Care (EPC) has focused on weaker organic revenue, falling productivity and lower operating margins, alongside a high net-debt-to-EBITDA ratio that has put potential dilution risk on investor radar. See our latest analysis for Edgewell Personal Care. At a share price of $21.56, Edgewell Personal Care has seen a 1 month share price return of 2.76% and a year to date share price return of 27.88%. However, the 1 year total shareholder return of 27.66%...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Earnings jump draws fresh focus to Equitable Holdings stock Equitable Holdings (EQH) just posted first quarter results that show net income of US$621 million compared with US$63 million a year earlier, while revenue for the quarter was US$4.23 billion versus US$4.58 billion. See our latest analysis for Equitable Holdings. At a share price of US$41.49, Equitable Holdings has a 30 day share price return of 9.79%, while its 1 year total shareholder return of 15.58% decline contrasts with an...

Patrick Industries stock performance snapshot Patrick Industries (PATK) has drawn investor attention after recent trading left the stock at US$85.13, with returns of about 4% over the past year and a little more than 100% over the past 3 years. See our latest analysis for Patrick Industries. Despite the recent pullback, with a 30 day share price return of a 26% decline and a 90 day share price return of a 36% decline, Patrick Industries still shows longer term momentum through a 3 year total...

Mueller Industries, Inc. ( NYSE:MLI ) announced strong profits, but the stock was stagnant. Our analysis suggests that...

The market for United Parcel Service, Inc.'s ( NYSE:UPS ) shares didn't move much after it posted weak earnings...

Shareholders appeared unconcerned with Kimberly-Clark Corporation's ( NASDAQ:KMB ) lackluster earnings report last...

We note that the The Western Union Company ( NYSE:WU ) President of Europe, Giovanni Angelini, recently sold US$57k...

In early May 2026, IES Holdings, Inc. reported Q2 2026 results showing sales of US$974.28 million and net income of US$109.91 million, with both quarterly and six-month earnings per share from continuing operations higher than a year earlier. Beyond the headline growth, the company pointed to especially strong contributions from its Communications and Infrastructure Solutions segments and a sharply higher backlog, supported by the recent acquisition of Gulf Island Fabrication. Next, we’ll...

McGraw Hill, Inc. ( NYSE:MH ) is possibly approaching a major achievement in its business, so we would like to shine...

Limbach Holdings, a US building systems company, recently reported quarterly results after the bell, following a prior period when it missed revenue expectations but exceeded EPS estimates, while current consensus points to flat year-on-year revenue. The key question for investors is whether management’s update on revenue trends and outlook confirms a slowdown in growth momentum relative to previous periods. We’ll now examine how expectations for flat revenue in the latest quarter could...

In late April 2026, CONMED Corporation reported first-quarter results with sales of US$317.05 million and higher earnings, raised its full-year 2026 revenue outlook to US$1.35–US$1.38 billion, and confirmed it had completed the divestiture of its remaining gastroenterology portfolio. Management’s decision to exit lower-margin gastroenterology products while simultaneously upgrading guidance and signaling interest in disciplined acquisitions highlights a sharpening focus on higher-margin...

Recent performance snapshot National Health Investors (NHI) has drawn attention after a one-month return of about a 9% decline and a past three-month return of roughly a 7% decline, against a last close of US$75.71. See our latest analysis for National Health Investors. That recent share price weakness, including the 1-month share price return of about a 9% decline, contrasts with a 1-year total shareholder return of 4.43% and a very large 79.88% total shareholder return over three years...

If you are wondering whether Plexus stock still offers value after its strong run, it helps to step back and look at what the recent share price is actually pricing in. The stock last closed at US$262.55, with returns of 5.4% over 7 days, 26.6% over 30 days, 72.5% year to date and 109.0% over the past year. This naturally raises questions about how much upside or risk is now on the table. Recent coverage has focused on Plexus in the context of broader moves within the electronic and...